CN102421449A - 含14型肺炎球菌糖的组合 - Google Patents

含14型肺炎球菌糖的组合 Download PDF

Info

Publication number
CN102421449A
CN102421449A CN2010800212325A CN201080021232A CN102421449A CN 102421449 A CN102421449 A CN 102421449A CN 2010800212325 A CN2010800212325 A CN 2010800212325A CN 201080021232 A CN201080021232 A CN 201080021232A CN 102421449 A CN102421449 A CN 102421449A
Authority
CN
China
Prior art keywords
seq
composition
los
amino acid
meningococcal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800212325A
Other languages
English (en)
Chinese (zh)
Inventor
P·科斯塔蒂诺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CN102421449A publication Critical patent/CN102421449A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CN2010800212325A 2009-03-24 2010-03-24 含14型肺炎球菌糖的组合 Pending CN102421449A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16299609P 2009-03-24 2009-03-24
US61/162,996 2009-03-24
PCT/IB2010/000735 WO2010109325A2 (en) 2009-03-24 2010-03-24 Combinations including pneumococcal serotype 14 saccharide

Publications (1)

Publication Number Publication Date
CN102421449A true CN102421449A (zh) 2012-04-18

Family

ID=42352288

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800212325A Pending CN102421449A (zh) 2009-03-24 2010-03-24 含14型肺炎球菌糖的组合

Country Status (9)

Country Link
US (1) US20120064104A1 (https=)
EP (1) EP2411044A2 (https=)
JP (2) JP5806204B2 (https=)
CN (1) CN102421449A (https=)
AU (1) AU2010227221B2 (https=)
CA (1) CA2756398A1 (https=)
NZ (1) NZ595223A (https=)
RU (2) RU2549438C2 (https=)
WO (1) WO2010109325A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110859957A (zh) * 2014-01-21 2020-03-06 辉瑞公司 包含缀合荚膜糖抗原的免疫原性组合物及其用途

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ515935A (en) 1999-05-19 2004-01-30 Chiron S Combination Neisserial compositions and vaccines for the prevention of infections due to Neisseria bacteria such as meningococcal meningitis
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
CN103533953A (zh) 2011-05-17 2014-01-22 葛兰素史密丝克莱恩生物有限公司 针对肺炎链球菌的疫苗
CN104428008B (zh) 2012-05-24 2020-10-09 美国政府(由卫生和人类服务部的部长所代表) 多价脑膜炎球菌缀合物及制备缀合物的方法
AU2013276083B2 (en) * 2012-06-14 2018-04-05 Institut Pasteur Vaccines for serogroup X meningococcus
WO2014016152A1 (en) 2012-07-27 2014-01-30 Institut National De La Sante Et De La Recherche Medicale Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
US20150344530A1 (en) * 2014-05-29 2015-12-03 Subhash V. Kapre Synthetic Peptides as Carriers for Conjugation with Polysaccharides
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
WO2023132795A2 (en) * 2022-01-05 2023-07-13 National University Of Singapore Modified bacterial glycans and conjugates thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014418A2 (en) * 2002-08-02 2004-02-19 Glaxosmithkline Biologicals S.A. Neisserial vaccine compositions comprising a combination of antigens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101515078B1 (ko) * 2005-12-22 2015-04-24 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014418A2 (en) * 2002-08-02 2004-02-19 Glaxosmithkline Biologicals S.A. Neisserial vaccine compositions comprising a combination of antigens

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GERMIE P.J.M. VAN DEN DOBBELSTEEN ET AL: "Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs", 《VACCINE》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110859957A (zh) * 2014-01-21 2020-03-06 辉瑞公司 包含缀合荚膜糖抗原的免疫原性组合物及其用途
CN110859957B (zh) * 2014-01-21 2024-04-12 辉瑞公司 包含缀合荚膜糖抗原的免疫原性组合物及其用途

Also Published As

Publication number Publication date
RU2011142747A (ru) 2013-04-27
US20120064104A1 (en) 2012-03-15
RU2549438C2 (ru) 2015-04-27
WO2010109325A2 (en) 2010-09-30
RU2014122163A (ru) 2015-12-10
AU2010227221B2 (en) 2015-01-22
JP2015163651A (ja) 2015-09-10
NZ595223A (en) 2013-12-20
JP5806204B2 (ja) 2015-11-10
WO2010109325A3 (en) 2011-01-20
CA2756398A1 (en) 2010-09-30
AU2010227221A1 (en) 2011-10-13
JP2012521404A (ja) 2012-09-13
EP2411044A2 (en) 2012-02-01

Similar Documents

Publication Publication Date Title
AU2010227220B2 (en) Combinations of meningococcal factor H binding protein and pneumococcal saccharide conjugates
US10478483B2 (en) Combinations of meningococcal factor H binding proteins
AU2010227221B2 (en) Combinations including pneumococcal serotype 14 saccharide
CN101951949B (zh) 脑膜炎球菌疫苗制剂
US20100189737A1 (en) Meningococcal vaccines including hemoglobin receptor
AU2014268243B2 (en) Combinations of meningococcal factor H binding protein and pneumococcal saccharide conjugates
AU2013202606A1 (en) Combinations of meningococcal factor H binding proteins

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: Basel

Applicant after: Novartis Ag

Address before: Basel

Applicant before: Novartis Vaccines & Diagnostic

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: NOVARTIS VACCINES + DIAGNOSTIC TO: NOVARTIS CO., LTD.

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120418